Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DXS InternationalAQSE:DXSP EV-to-EBIT is -10.91 as of Aug. 20, 2026. The stock has 5 warning signs investors should review. Among 474 Healthcare Providers & Services companies, DXS International ranks worse than 210970.25% on this metric.
The historical rank and industry rank for DXS International's EV-to-EBIT or its related term are showing as below:
AQSE:DXSP'
s EV-to-EBIT Range Over the Past 10 Years
Min: -815.26 Med: -6.63 Max: 102.26
Current: -10.91
During the past 11 years, the highest EV-to-EBIT of DXS International was 102.26. The lowest was -815.26. And the median was -6.63.
AQSE:DXSP's EV-to-EBIT is ranked worse than 100% of 474
companies
in the Healthcare Providers & Services industry
Industry Median: 15.98
vs AQSE:DXSP: -10.91
DXS International (AQSE:DXSP) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
DXS International's Enterprise Value for the quarter that ended in Apr. 2025 was £1.48 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DXS International's EBIT for the trailing twelve months (TTM) ended in Apr. 2025 was £-0.13 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DXS International EV-to-EBIT Related Terms
DXS International EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for DXS International's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AQSE:DXSP vs VEEV, BTSG, HQY: EV-to-EBIT Comparison
For the Health Information Services subindustry, DXS International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DXS International EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DXS International's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where DXS International's EV-to-EBIT falls into.
DXS International's current Enterprise Value is £1.39 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DXS International's EBIT for the trailing twelve months (TTM) ended in Apr. 2025 was £-0.13 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DXS International (AQSE:DXSP) has a EV-to-EBIT of -10.91 as of Aug. 20, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on DXS International and its competitors. According to the industry distribution chart, DXS International ranks #999999 out of 474 companies in the Healthcare Providers & Services industry.
Is DXS International's EV-to-EBIT too high?
DXS International's current EV-to-EBIT is -10.91. Based on the distribution chart, DXS International ranks #999999 out of 474 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does DXS International's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DXS International ranks #999999 out of 474 companies for EV-to-EBIT. This places DXS International in the lower half of its industry. The industry median EV-to-EBIT is 15.98. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.98, based on 474 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on DXS International and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DXS International's current EV-to-EBIT is -10.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
Based on GuruFocus' analysis, DXS International (AQSE:DXSP) is currently considered Fairly Valued. The stock's GF Value™ is £0.02, compared to a current price of £0.02 — trading 5% above its estimated fair value. The current EV-to-EBIT is -10.91. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For DXS International (AQSE:DXSP), the current EV-to-EBIT is -10.91 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AQSE:DXSP has been successfully added to your 
